Gene expression patterns in livers of Hispanic patients infected with hepatitis C virus

Peter A Hevezi1, Edward Tom, Keith Wilson

  • 1FACET Biotech, 1500 Seaport Blvd, Redwood City, CA 94063, USA.

Autoimmunity
|August 26, 2011
PubMed

Insights

This study identified novel genes and pathways affected by hepatitis C virus (HCV) infection in Hispanic patients. Treatment with interferon (IFN)-α and ribavirin induced distinct gene expression changes in the liver.

Area of Science:

  • Hepatology
  • Virology
  • Genomics

Background:

  • Hepatitis C virus (HCV) infection significantly impacts liver function and cellular pathways.
  • Understanding host gene expression changes is crucial for developing effective therapies.
  • Hispanic populations may exhibit unique responses to HCV infection.

Purpose of the Study:

  • To identify genes differentially expressed in the livers of Hispanic patients with HCV infection.
  • To investigate gene expression changes following anti-HCV therapy (pegylated interferon-α + ribavirin).
  • To explore the functional pathways associated with HCV infection and treatment response.

Main Methods:

  • Gene expression profiling of liver biopsies from HCV-infected and uninfected Hispanic individuals.
  • Analysis of gene expression before and after antiviral therapy.
  • Pathway analysis to identify biological processes affected by HCV and treatment.

Main Results:

  • HCV infection induced significant up- and down-regulation of numerous genes in the liver.
  • Key affected pathways included interferon (IFN)-inducible responses, immune cell trafficking, inflammation, anti-microbial responses, and cancer-related pathways.
  • Novel genes, such as CD47, were identified as being modulated by HCV infection.
  • Antiviral therapy resulted in fewer and smaller gene expression changes compared to infection, with specific genes like MX2 and HBP1 being induced.

Conclusions:

  • This is the first study to characterize gene expression changes in the livers of HCV-infected Hispanic patients.
  • HCV infection profoundly alters liver gene expression, implicating multiple immune and cellular pathways.
  • The study identified novel genes associated with HCV and provides insights into the molecular effects of standard anti-HCV therapy in the liver.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...